Big Pharma push back on first Medicare drug price cuts
Major pharmaceutical companies lashed out following a landmark deal unveiled Thursday to cut the costs of 10 key medicines, with some saying the price-setting process was not transparent. Novartis, whose heart failure treatment Entresto is among the 10 selected medicines, pushed back against the price-setting process as “not objective or transparent…
Major pharmaceutical companies lashed out following a landmark deal unveiled Thursday to cut the costs of 10 key medicines, with some saying the price-setting process was not transparent. Novartis, whose heart failure treatment Entresto is among the 10 selected medicines, pushed back against the price-setting process as “not objective or transparent…
Read More
About Author
